XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Operating activities      
Net income / (loss) $ 72,111 $ 38,453 $ (3,573)
Adjustments to reconcile net income / (loss) to net cash provided by (used in) operating activities:      
Equity-based compensation 15,718 12,553 744
Accretion of income on other investments, at fair value 0 (124) (424)
Loss / (gain) on other investments, at fair value (35,421) (43,413) (1,080)
Loss / (gain) on other investments, sold not yet purchased (830) (1,063) 0
(Income) / loss from equity method affiliates (36,010) 2,955 553
Depreciation and amortization 371 334 318
Impairment of goodwill 0 7,883 0
Amortization of discount on debt 860 736 548
Deferred tax provision / (benefit) (2,071) (8,877) (678)
Other non-operating income - forgiveness of debt (2,127) 0 0
Change in operating assets and liabilities, net:      
Change in receivables from/ payables to brokers, dealers, and clearing agencies (11,257) (41,368) 73,343
Change in receivables from / payables to related parties, net (3,872) (2,346) 327
(Increase) decrease in other receivables 726 42,696 (34,535)
(Increase) decrease in investments-trading 19,096 64,891 (6,617)
(Increase) decrease in receivables under resale agreement 2,540,698 1,783,659 132,228
(Increase) decrease in other assets (4,858) 4,340 (3,768)
Increase (decrease) in accounts payable and other liabilities (19,307) 24,552 7,855
Increase (decrease) in accrued compensation 8,218 10,313 (1,208)
Increase (decrease) in trading securities sold, not yet purchased 18,073 (33,508) (42,175)
Increase (decrease) in securities sold under agreement to repurchase (2,541,797) (1,821,231) (137,321)
Net cash provided by (used in) operating activities 18,321 41,435 (15,463)
Investing activities      
Purchase of investments - other investments, at fair value (123,098) (62,282) (1,927)
Purchase of investments - other investments sold, not yet purchased, at fair value (59,098) (12,519) 0
Sales and returns of principal - other investments, at fair value 112,013 54,748 10,114
Sales and returns of principal - other investments sold, not yet purchased, at fair value 56,820 20,997 0
Investments in equity method affiliates (8,143) (12,675) (4,352)
Purchase of furniture, equipment, and leasehold improvements (1,028) (217) (101)
Net cash provided by (used in) investing activities (22,534) (11,948) 3,734
Financing activities      
Proceeds from draws on revolving credit facility 17,500 17,500 4,777
Repayment of draws on revolving credit facility (17,500) (17,500) 0
Proceeds from PPP loan 0 2,166 0
Proceeds from non-convertible debt 0 4,500 0
Repayment of debt (2,400) (9,163)  
Payments for debt issuance costs 0 (24) 0
Proceeds from redeemable financial instrument 0 0 1,268
Repayment of redeemable financial instrument (4,000) (4,921) (1,500)
Cash used to net share settle equity awards (378) (54) (128)
Proceeds from issuance of Common Stock 9,076 0 0
Purchase and retirement of Common Stock (857) (2,142) (299)
Proceeds from other non-controlling interest investment 17,095 13,489 2,550
Other non-controlling interest distributions (2,734) 0 0
Operating LLC non-controlling interest distributions (1,970) (35) (213)
Cohen & Company Inc. dividends (671) (27) (519)
Net cash provided by (used in) financing activities 13,161 3,789 5,936
Effect of exchange rate on cash (377) 416 (9)
Net increase (decrease) in cash and cash equivalents 8,571 33,692 (5,802)
Cash and cash equivalents, beginning of period 41,996 8,304 14,106
Cash and cash equivalents, end of period $ 50,567 $ 41,996 $ 8,304